1-4 of 4
Andrea L. Dewar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dysregulation of bone remodeling by imatinib mesylate

Kate Vandyke, Stephen Fitter, Andrea L. Dewar, Timothy P. Hughes, Andrew C. W. Zannettino
Journal: Blood
Blood (2010) 115 (4): 766–774.
https://doi.org/10.1182/blood-2009-08-237404
Published: 2010
Journal Articles

Long-term imatinib therapy promotes bone formation in CML patients

Clinical Trials & Observations
Stephen Fitter, Andrea L. Dewar, Panagiota Kostakis, L. Bik To, Timothy P. Hughes, Marion M. Roberts, Kevin Lynch, Barrie Vernon-Roberts, Andrew C. W. Zannettino
Journal: Blood
Blood (2008) 111 (5): 2538–2547.
https://doi.org/10.1182/blood-2007-07-104281
Published: 2008
Includes: Supplemental data
Journal Articles

Imatinib as a potential antiresorptive therapy for bone disease

Andrea L. Dewar, Amanda N. Farrugia, Mark R. Condina, L. Bik To, Timothy P. Hughes, Barrie Vernon-Roberts, Andrew C. W. Zannettino
Journal: Blood
Blood (2006) 107 (11): 4334–4337.
https://doi.org/10.1182/blood-2005-09-3568
Published: 2006
Journal Articles

Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib

Andrea L. Dewar, Antony C. Cambareri, Andrew C. W. Zannettino, Bernadette L. Miller, Kathleen V. Doherty, Timothy P. Hughes, A. Bruce Lyons
Journal: Blood
Blood (2005) 105 (8): 3127–3132.
https://doi.org/10.1182/blood-2004-10-3967
Published: 2005